NCT06633666Recruiting
Acupuncture for Post COVID-19 Condition (Long COVID) Neuropsychiatric Symptoms
Acupuncture for Long COVID Neuropsychiatric Symptoms: a Pragmatic,Randomized Clinical Trial
Source: ClinicalTrials.gov · Last updated 13 Nov 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
In this study, a 12-week pragmatic, randomized, double-blinded clinical trial will be conducted to evaluate the efficacy of acupuncture for the treatment of long Covid neuropsychiatric symptoms and provide reference for clinical non-drug treatment.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 160 (estimated)
- First submitted
- 5 Oct 2024
- Start date
- 30 Jul 2023
- Primary completion date
- 31 Jan 2026
- Lead sponsor
- Hong Kong Baptist University
- Diseases
- Long COVID and ME/CFS
- NCT number
- NCT06633666
What you commit to
- Study type: Interventional
- Planned participants: 160
- From 30 Jul 2023 to the primary completion date, 31 Jan 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- suicidal tendencies (attempted suicide in the 12 months before the study);
- have surgery within two months before the study or will have a scheduled surgery during the study;
- patients who received acupuncture treatment 1 month before the start of the study;
Other illness
- patients with a history of chronic neuropsychiatric symptoms;
- cardiovascular diseases pre-existing to the Covid-19 episode such as arrhythmia, heart failure, myocardial infarction, and patients with cardiac pacemakers;
- documented pre-existing history of psychiatric illness, including substance abuse;
- any chronic or remote neurological disorder (i.e. stroke, head trauma, epilepsy, tumor);
- acute brain injury or acute encephalopathy from another etiology than Covid-19 (e.g., sepsis, liver or renal failure, alcohol or drug withdrawal, drug toxicity);
- open-heart cardiac surgery or cardiac arrest during the last 6 months;
- patients who were unable to complete the assessment during screening due to severe mental, cognitive, or emotional impairment
Other
- those who participated in other clinical trials within one month;
- pregnant or lactating female patients;
Who the study is looking for
- meet the clinical diagnosis of Long COVID by the World Health Organization (WHO), with no neuropsychiatric symptoms 1 year before infection with Covid-19, and continue to have at least one neuropsychiatric symptom for 2 months after SARS-CoV-2 turned negative 3 months above;
- aged 12 to 80 years;
- willing and able to consent, and complete all assessment and study procedures
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Linda Zhong Coordinator of this site? Confirm its status | Kowloon Tong | Hong Kong SAR China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.